Global Convergence Global Convergence

WHO to Start Prequalifying Biosimilars for Cancer Treatment

4 May 2017 - The World Health Organization (WHO) announced its plan to pilot a new project to prequalify biosimilars for cancer treatment. The decision was announced at a 2-day conference in Geneva about how to increase access to biotherapeutic medicines. The move is expected to bring down the prices of the most expensive cancer treatments available, making them more accessible to low- and middle-income countries.

Read More

About convergence

convergence is an environmental, health, safety and social management consultancy that specializes in multi-country (international) projects and programs.  We are able to meet our clients’ needs on a global scale while recognizing the important regional differences that our clients face in conducting business.  We are one of the leading international EHS audit consultancies; and our country health and safety legal compliance tools for offices, retail and service sectors, known as CORE, are the foremost resource of its kind.